Clinical Trials Browser

Phase 2 × Interventional × Dietary Supplements × Clear all

NCT07242365 2026-02-05

Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy

Phase 2 Active not recruiting

Locally Advanced Head and Neck Carcinoma

NCT07064668 2025-07-15

Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT03476330 2025-04-27

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

Phase 2 Active not recruiting

Classical hematology

Carcinoma, Squamous Cell, Fanconi Anemia

NCT02745197 2024-09-19

A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT01968590 2022-05-25

VitDBoneNF1

Phase 2 Terminated

Neurofibromatosis 1

NCT03628144 2020-09-10

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Phase 2 Completed

56 enrolled 5 charts

GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating